Abubakar, Muhaver O.

HRN: 28-18-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2026
CEFUROXIME 750MG (VIAL)
03/22/2026
03/29/2026
IV
270mg
Q8
PCAP T/c CSOM
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  PneumoniaEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines